483 GlaxoSmithKline Biologicals Jun 2013

483 GlaxoSmithKline Biologicals Jun 2013

Susan Jackson FDA, Cynthia Jim FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Biologicals - Dresden, Germany facility and issued inspectional observations (via FDA 483) on 27 Jun 2013.

Product details

  • Category: Biologics
  • Inspection end: 27 Jun 2013
  • Location: Dresden, Germany
  • FEI: 3004835618
Add To Cart